Physician profile
Christian L Castaneda
NPI 1609262435
$34,153.29
in general payments reported to CMS, 2019-2025
19 companies · $29K in 2025
The $29K reported for 2025 was more than what 98% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.00 · 2020: $563 · 2021: $518 · 2022: $1,196 · 2023: $1,208 · 2024: $1,157 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Education: $5,599 · Travel and Lodging: $4,314 · Food and Beverage: $4,212 · Consulting Fee: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,100.00 |
| Education | $5,598.99 |
| Travel and Lodging | $4,314.11 |
| Food and Beverage | $4,211.99 |
| Consulting Fee | $1,581.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17,801.57 | 2020-2025 | Nucala, Trelegy Ellipta |
| Intuitive Surgical, INC. | $8,025.54 | 2025 | |
| Olympus Corporation of The Americas | $2,048.92 | 2025 | Spiration Valve System |
| Genzyme Corporation | $1,808.71 | 2025 | |
| Insmed, INC. | $1,435.86 | 2022-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $761.91 | 2020-2023 | Stiolto Respimat |
| Astrazeneca Pharmaceuticals Lp | $725.05 | 2022-2025 | Tezspire, Fasenra, Breztri |
| Mallinckrodt Hospital Products INC. | $375.00 | 2020-2021 | |
| Inari Medical, INC. | $240.23 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Regeneron Healthcare Solutions, INC. | $193.90 | 2023-2024 | Dupixent |
| Tactile Systems Technology INC | $162.70 | 2025 | Flexitouch Plus, Nimbl |
| Penumbra, INC. | $147.09 | 2022 | |
| Pulmonx Corporation | $105.55 | 2023-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Boston Scientific Corporation | $84.89 | 2025 | General - Pulmonary |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $70.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.53 | 2022 | |
| Philips North America LLC | $19.76 | 2023 | |
| Abbvie INC. | $17.09 | 2023 | Avycaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Castaneda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.